LENZ Therapeutics Inc (LENZ)
34.00
-2.39
(-6.57%)
USD |
NASDAQ |
Nov 14, 16:00
35.62
+1.62
(+4.76%)
After-Hours: 17:58
LENZ Therapeutics Shareholders Equity (Quarterly): 215.28M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 215.28M |
| June 30, 2024 | 192.92M |
| March 31, 2024 | 198.17M |
| Date | Value |
|---|---|
| December 31, 2023 | -92.71M |
| September 30, 2023 | -69.57M |
| December 31, 2022 | -24.17M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-92.71M
Minimum
Dec 2023
215.28M
Maximum
Sep 2024
69.99M
Average
84.38M
Median
Shareholders Equity (Quarterly) Benchmarks
| Oruka Therapeutics Inc | -- |
| TruBridge Inc | 181.10M |
| PetMed Express Inc | 96.43M |
| Streamline Health Solutions Inc | 15.90M |
| R1 RCM Inc | 2.811B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 224.01M |
| Total Liabilities (Quarterly) | 8.727M |